These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10809796)
1. G(-699)/C polymorphism in the bradykinin-1 receptor gene in patients with renal failure. Knigge H; Blüthner M; Brüntgens A; Sator H; Ritz E Nephrol Dial Transplant; 2000 May; 15(5):586-8. PubMed ID: 10809796 [TBL] [Abstract][Full Text] [Related]
2. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254 [TBL] [Abstract][Full Text] [Related]
3. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Maltais I; Bachvarova M; Maheux P; Perron P; Marceau F; Bachvarov D Can J Physiol Pharmacol; 2002 Apr; 80(4):323-7. PubMed ID: 12025967 [TBL] [Abstract][Full Text] [Related]
4. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885 [TBL] [Abstract][Full Text] [Related]
5. Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure. Bachvarov DR; Landry M; Pelletier I; Chevrette M; Betard C; Houde I; Bergeron J; Lebel M; Marceau F J Am Soc Nephrol; 1998 Apr; 9(4):598-604. PubMed ID: 9555662 [TBL] [Abstract][Full Text] [Related]
6. Increased frequency of G-protein beta 3-subunit 825 T allele in dialyzed patients with type 2 diabetes. Blüthner M; Schmidt S; Siffert W; Knigge H; Nawroth P; Ritz E Kidney Int; 1999 Apr; 55(4):1247-50. PubMed ID: 10200987 [TBL] [Abstract][Full Text] [Related]
7. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356 [TBL] [Abstract][Full Text] [Related]
8. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes. Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117 [TBL] [Abstract][Full Text] [Related]
9. Polymorphic genes for kinin receptors, nephropathy and blood pressure in type 2 diabetic patients. Zychma MJ; Gumprecht J; Trautsolt W; Szydlowska I; Grzeszczak W Am J Nephrol; 2003; 23(2):112-6. PubMed ID: 12481150 [TBL] [Abstract][Full Text] [Related]
10. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653 [TBL] [Abstract][Full Text] [Related]
11. The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis. Bagci B; Bagci G; Candan F; Ozdemir O; Sezgin I Int Urol Nephrol; 2015 Mar; 47(3):551-6. PubMed ID: 25655256 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes. Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. The End-Stage Renal Disease Study Group. Zychma MJ; Gumprecht J; Zukowska-Szczechowska E; Grzeszczak W J Am Soc Nephrol; 1999 Oct; 10(10):2120-4. PubMed ID: 10505688 [TBL] [Abstract][Full Text] [Related]
15. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. Chang HR; Cheng CH; Shu KH; Chen CH; Lian JD; Wu MY J Chin Med Assoc; 2003 Jan; 66(1):51-6. PubMed ID: 12728975 [TBL] [Abstract][Full Text] [Related]
16. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. El-Din Bessa SS; Hamdy SM Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735 [TBL] [Abstract][Full Text] [Related]
18. Association of the human bradykinin B2 receptor gene with chronic renal failure. Jozwiak L; Drop A; Buraczynska K; Ksiazek P; Mierzicki P; Buraczynska M Mol Diagn; 2004; 8(3):157-61. PubMed ID: 15771553 [TBL] [Abstract][Full Text] [Related]
19. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365 [TBL] [Abstract][Full Text] [Related]
20. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]